Drug interaction alerts are posing problems

September 1997

Drug interaction alerts are posing problems for pharmacists. ...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

How herbs interact with "regular" drugs
Pulmicort Turbuhaler, a new DRY POWDER inhaler for asthma
Osteoarthritis Two unique new treatments for osteoarthritis of the knee
Pediatrics What do you tell a parent who asks if an antibiotic tastes good?
Pediatrics Ritalin (methylphenidate) to children with epilepsy
Pediatrics Efalex Focus, a new dietary supplement for children
Dermatology Now warning patients NOT to use Skin-Cap
Diabetes Rezulin (troglitazone) is now approved for INITIAL therapy of type 2 diabetes
Diabetes Medicare will cover more diabetes supplies and services
Diabetes Allow pharmacists to join together in networks to provide pharmaceutical care SERVICES
Breast Cancer Femara (Fe-MAR-a, letrozole), a new hormonal therapy for advanced breast cancer
Breast Cancer New screening device to help detect breast cancer
Cardiology Nicotine replacement therapy even for patients with coronary artery disease
Actis, a new Rx device for impotence
OTC product called Rejoyn
Ginkgo to try to improve sexual dysfunction caused by antidepressants
Interactions Drug interaction alerts are posing problems
Neurology Pain Duract (bromfenac) for pain